Compounds > garenoxacin
Page last updated: 2024-09-03

garenoxacin and gemifloxacin

garenoxacin has been researched along with gemifloxacin in 6 studies

Compound Research Comparison

Studies
(garenoxacin)		Trials
(garenoxacin)		Recent Studies (post-2010)
(garenoxacin)		Studies
(gemifloxacin)		Trials
(gemifloxacin)		Recent Studies (post-2010) (gemifloxacin)
19519463204680

Protein Interaction Comparison

ProteinTaxonomygarenoxacin (IC50)gemifloxacin (IC50)
DNA gyrase subunit BStaphylococcus aureus5.6
DNA gyrase subunit AEscherichia coli K-120.5
DNA gyrase subunit BEscherichia coli K-120.5
DNA topoisomerase 4 subunit AStaphylococcus aureus0.3
DNA gyrase subunit AStaphylococcus aureus5.6

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Inagaki, H; Kitamura, T; Komoriya, S; Kuroyanagi, J; Miyauchi, RN; Nagamochi, M; Odagiri, T; Sugimoto, Y; Takahashi, H1
Blaskovich, MAT; Pham, TDM; Ziora, ZM1
Brady, SF; Koirala, B; Peek, J1
Goldstein, EJ1
Bébéar, C; Bébéar, CM; Pereyre, S; Renaudin, H1
Hoban, DJ; Noreddin, AM; Ostroski, M; Reese, AA; Zhanel, GG1

Reviews

1 review(s) available for garenoxacin and gemifloxacin

ArticleYear
Quinolone antibiotics.
    MedChemComm, 2019, Oct-01, Volume: 10, Issue:10

    Topics:

2019

Other Studies

5 other study(ies) available for garenoxacin and gemifloxacin

ArticleYear
Design, synthesis, and biological evaluations of novel 7-[7-amino-7-methyl-5-azaspiro[2.4]heptan-5-yl]-8-methoxyquinolines with potent antibacterial activity against respiratory pathogens.
    Journal of medicinal chemistry, 2013, Mar-14, Volume: 56, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Drug Design; Fluoroquinolones; Haemophilus influenzae; Male; Mice; Microbial Sensitivity Tests; Quinolones; Rats; Respiratory Tract Infections; Spiro Compounds; Staphylococcus aureus; Streptococcus pneumoniae

2013
Synthesis and evaluation of dual-action kanglemycin-fluoroquinolone hybrid antibiotics.
    Bioorganic & medicinal chemistry letters, 2022, 02-01, Volume: 57

    Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; HEK293 Cells; Humans; Microbial Sensitivity Tests; Rifamycins; Staphylococcus aureus

2022
Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Sep-01, Volume: 35, Issue:Suppl 1

    Topics: Abdominal Abscess; Anti-Bacterial Agents; Aza Compounds; Bacteremia; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Carbapenems; Clinical Trials as Topic; Ertapenem; Fluoroquinolones; Gemifloxacin; Humans; Indoles; Lactams; Moxifloxacin; Naphthyridines; Quinolines; Quinolones

2002
In vitro activities of the newer quinolones garenoxacin, gatifloxacin, and gemifloxacin against human mycoplasmas.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:8

    Topics: Anti-Infective Agents; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Humans; Microbial Sensitivity Tests; Mycoplasma; Mycoplasma Infections; Naphthyridines; Quinolones

2004
Comparative pharmacodynamics of garenoxacin, gemifloxacin, and moxifloxacin in community-acquired pneumonia caused by Streptococcus pneumoniae: a Monte Carlo simulation analysis.
    Clinical therapeutics, 2007, Volume: 29, Issue:12

    Topics: Anti-Bacterial Agents; Area Under Curve; Aza Compounds; Community-Acquired Infections; Fluoroquinolones; Gemifloxacin; Humans; Monte Carlo Method; Moxifloxacin; Naphthyridines; Pneumococcal Infections; Quinolines; Respiratory Mucosa

2007